EQS-Ad-hoc: aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG (the "Company") announces with reference to the ad hoc release published on October 15, 2024 at 11:25 p.m. regarding a possible cyberattack that the company's IT systems are being restarted step by step. Production was resumed after a short interruption and was almost unaffected. The ad hoc announcement on October 15, 2024 was directly preceded by information provided to the Company by the relevant investigating authorities regarding investigations initiated ex officio on suspicion of a cyberattack on the Company. According to the ongoing internal investigation of the incident by IT specialists and the latest information provided to the Company by the investigating authorities, it can be assumed at this point in time that no irregularities, in particular data outflows, have occurred. The Company expects to be able to resume normal operations by the end of next week.
Contact: If you have any questions, please contact: aap Implantate AG; R. Di Girolamo; Chairman of the Management Board/CEO; Lorenzweg 5; D-12099 Berlin Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de
End of Inside Information
18-Oct-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | aap Implantate AG |
Lorenzweg 5 | |
12099 Berlin | |
Germany | |
Phone: | +49 (0) 30 75 019-0 |
Fax: | +49 (0) 30 75 019-111 |
E-mail: | info@aap.de |
Internet: | www.aap.de |
ISIN: | DE000A3H2101 |
WKN: | A3H210 |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2011859 |
End of Announcement | EQS News Service |
|
2011859 18-Oct-2024 CET/CEST
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.